ONCOtherapeutics Competitors and Similar CompaniesClear all
ONCOtherapeutics's competitors and similar companies include CEL-SCI, Abliva and Topas Therapeutics.
 ONCOtherapeutics ONCOtherapeutics is a contract research organization that runs multiple clinical trials. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | |
Founding Date | Founding Date 2005 | Founding Date 1983 | Founding Date 2000 | Founding Date 2013 |
Type | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations West Hollywood, US HQ | Locations Vienna, US HQ | Locations Lund, SE HQ | Locations Hamburg, DE HQ Bremen, DE |
Employees | Employees 13 | Employees N/A | Employees 950% increase | Employees N/A |
Financial | ||||
Net income | Net income N/A | Net income ($25.4m) (FY, 2025) | Net income (kr90m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 10.8m | Total funding raised $ 20.8m |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View companyTopas Therapeutics
HQ
Hamburg, DE
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company